top of page
Asha's Focus: Devasting Neurological Conditions
Neurodegeneration
Neuro-oncology
Neuromuscular
Neurovascular
& Stroke
Asha Therapeutics Internal Programs
Asha Research Labs Partnered Projects
Novel Design Preclinical Optimization
APOE4
LysoPRISM™ Compound
Tau
AcetylPRISM™ Compound
Sigma Factor
GenePRISM™ Antibiotic
Undisclosed
Asha Research Labs Partnered Projects
Asha Therapeutics Internal Programs
Asha Research Labs Partnered Projects
ASHA-091
Alzheimer's, Parkinson's
& ALS
ASHA-624
ALS, MS, Glaucoma
Peripheral Neuropathies
ASHA-044
Colorectal Cancer
Hepatocellular Carcinoma
Melanoma
Novel Design Lead Optimization IND-Enabling Clinical Trials
Small Molecule - DRP1 Inhibitor
Intra-molecular Glue - SARM1 Inhibitor
Targeted Protein Degrader - Beta-Catenin
ASHA-197
Pancreatic Cancer
Lung Cancer
Colorectal Cancer
Molecular Glue - Mutant RAS
ASHA-711
Alzheimer's Disease
Lysosomal Degrader - APOE4
Undisclosed
Asha Research Labs
Partnered Asset
Undisclosed
bottom of page